Scilex Holding (SCLXW)
0.11
0.00 (0.92%)
At close: Mar 10, 2025, 3:14 PM
0.21
89.95%
After-hours: Mar 11, 2025, 07:21 PM EDT
0.92% (1D)
| Bid | 0.18 |
| Market Cap | 85.16M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.23 |
| Volume | 5 |
| Avg. Volume (20D) | 13,121.693 |
| Open | 0.11 |
| Previous Close | 0.11 |
| Day's Range | 0.11 - 0.11 |
| 52-Week Range | 0.11 - 0.11 |
| Beta | 1.16 |
About SCLXW
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company's principal product includes ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102 or SEMDEXA, a viscous gel formulation of corticosteroid f...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date n/a
Employees 117
Stock Exchange NASDAQ
Ticker Symbol SCLXW
Website https://www.scilexholding.com